Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
MRVL.Vthis companyMarvel Biosciences Corp.	CA$0.11	-3.74×	-2.07×	0×	-5.38×	-160.0%	0.0%	0.0%	0.0%	55.2%	73.6%	-13.9%	-0.58×	-1.12×	-4.66×	0.08×	0.0%	2	-56.02	2	C
BETR.CNBetterLife Pharma Inc.	CA$0.22	-4.9×	-0.75×	0×	-4.53×	-113.2%	0.0%	0.0%	0.0%	15.3%	32.4%	-8.6%	-0.09×	-0.49×	-7.8×	0.03×	0.0%	3	-83.43	2	C
BLAB.CNBritannia Life Sciences Inc.	CA$0.07	1.12×	0.7×	30.75×	-9.69×	-103.5%	8.2%	-306.8%	2753.4%	63.0%	-6.6%	-7.9%	0.01×	0.79×	-57.36×	6.57×	0.0%	6	3.03	4	A+
DHB.VDelivra Health Brands Inc.	CA$0.08	-1.39×	1.41×	0.36×	-1.32×	-688.8%	38.3%	-23.8%	-26.1%	-101.3%	-44.4%	-20.4%	1.08×	0.22×	-12.63×	2.62×	0.0%	1	-33.49	1	C-
GLOW.CNGlow Lifetech Corp.	CA$0.04	-16.67×	3.82×	5.04×	-19.18×	234.0%	16.9%	-35.4%	-30.1%	-22.8%	-26.3%	-1.1%	0.02×	2.78×	0×	2.09×	0.0%	4	-1.54	2	C+
MDMA.CNPharmala Biotech Holdings Inc.	CA$0.17	-6.19×	5.47×	22.2×	-6.47×	-266.4%	-139.6%	-355.6%	-359.2%	-88.5%	-87.6%	-7.8%	0×	0.02×	0×	1.71×	0.0%	2	5.56	1	D+
Peer median	—	-4.9×	1.41×	5.04×	-6.47×	-113.2%	8.2%	-35.4%	-26.1%	-22.8%	-26.3%	-7.9%	0.01×	0.22×	-7.8×	2.09×	0.0%	3	-1.54	2	—